A sustained response to low dose interferon-α in a case of refractory pure red cell aplasia
- 3 September 2004
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 73 (4) , 300-303
- https://doi.org/10.1111/j.1600-0609.2004.00291.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath‐1HEuropean Journal of Haematology, 2003
- Hematologic malignancies: New developments and future treatmentsSeminars in Oncology, 2002
- The effect of treatment with Campath‐1H in patients with autoimmune cytopeniasBritish Journal of Haematology, 2001
- The CD52 antigen and development of the CAMPATH antibodiesCytotherapy, 2001
- Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative DisordersMedical Oncology, 2001
- Pure red cell aplasiaBritish Journal of Haematology, 2000
- Pure Red-Cell Aplasia Associated with Clonal Expansion of Granular Lymphocytes Expressing Killer-Cell Inhibitory ReceptorsNew England Journal of Medicine, 1999
- Does a Low Level of Expression of HLA Molecules Engender Autoimmunity?New England Journal of Medicine, 1999
- MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK ActivityScience, 1991
- Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.Journal of Clinical Investigation, 1991